AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ २९.७६
arrow_downward
-०.४३%(-०.१३) 1D
नोभेम्बर १८, १०:२७:०७ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ २९.५७
High
US$ ३०.४८
Low
US$ २९.५३
Mkt. cap
१.७८ अरब
Avg. vol.
१२.१३ लाख
Volume
२७.२३ हजार
52-wk high
US$ ४४.०७
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ २९.५७
High
US$ ३०.४८
Low
US$ २९.५३
Mkt. cap
१.७८ अरब
Avg. vol.
१२.१३ लाख
Volume
२७.२३ हजार
52-wk high
US$ ४४.०७
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
TradingView
·
१ घण्टा पहिले
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Trade Mixed Ahead of FOMC Minutes— NVDA, AAOI, PANW in Focus (UPDATED)
San Luis Obispo Tribune
·
३९ मिनेट पहिले
S&P 500, Nasdaq open higher as Nvidia forecast eases AI jitters
Coinpaper
·
२८ मिनेट पहिले
Dow Jones: Wall Street Eyes Rebound as Morgan Stanley Targets S&P 500 at 8,700
FOREX.com
·
३ घण्टा पहिले
S&P 500 Quietly Shrugs Off the Bitcoin and Silver Selloff
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc